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Purpose: Respiratory function impacts on musical expression for wind/brass (W/B) musicians.
Investigation of musicians’ respiratory health to date has rarely progressed further than assess-
ments of flow limitation through spirometry. This study aimed to compare W/B musicians’
respiratory function to a non-wind/brass (NW/B) group with a comprehensive respiratory func-
tion assessment.
Methods: Non-smoking, non-asthmatic participants aged 18e60 years completed a respiratory
health questionnaire followed by spirometry, static lung volumes, respiratory mechanics, using
forced oscillations, gas transfer and airway responsiveness (AR). Measurements were compared
between participant groups using T-tests and linear regression modelling.
Results: Data from 102 participants (55 W/B musicians and 47 NW/B subjects) were included in
the analysis. There were no differences between the two groups for any spirometry or lung
volume outcomes, with the exception of RV/TLC which was decreased among W/B musicians
(pZ 0.03). Measures of gas transfer and ARwere similar between participant groups. Resistance
at 6 Hz, measured by forced oscillation, was increased amongW/Bmusicians compared to NW/B
musicians (pZ 0.02) but reactance at 6 Hz was similar between the groups (pZ 0.10).
Conclusions: The results suggest that W/B musicians’ do not have altered respiratory function
when compared to a non-musical control group. However, increased Rrs6may indicate inflamma-
tory, remodelling or other pathophysiological processes associated with W/B playing. Although
the difference between groups was small it warrants further investigation.
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other respiratory conditions. A current asthmatic wasIn order to play a wind or brass (W/B) instrument, one must
learn to manipulate airflow with precision, creating and
sustaining the pressures and flows required by the instru-
ment. Breath control is an important aspect of W/B
instrumental pedagogy.1,2 Any condition which interferes
with respiration control is a potential hindrance for W/B
musicians.3 The effect on respiratory function of playing
a W/B instrument is uncertain. Studies have suggested that
playing a W/B instrument is associated with ‘better’ lung
function, for example, larger vital capacity (VC).4e6 On the
other hand, there are data to indicate such an activity may
have deleterious impacts on the lungs.7,8 In a small study,
Plamenac and Niculin8 observed “marked eosinophilia” in
sputum samples of W/B musicians, while Deniz et al.7
reported decreased spirometric measurements among
Naval Band musicians compared to non-musicians in the
Navy. In addition a significant negative correlation between
duration of practice and forced vital capacity (FVC) was
also reported in the latter study.7 A number of other studies
have not found any adverse or beneficial effect of W/B
playing.9e11
It is feasible that the repeated deep inhalations,
increased respiratory volumes and/or pressures and the
prolonged expirations against a resistance required to play
W/B instruments may lead to altered small airway or distal
lung abnormalities. Therefore it is critical that studies
aiming to document the impact of playing wind/brass
instruments include assessments of respiratory function
sensitive to the peripheral lung.
The majority of studies to date have restricted their
assessments of musicians’ lung function to that of spi-
rometry4,7,9e13 and/or static lung volumes,4e6,9,10,13e16
and it is possible that subtle changes occurring in the
peripheral lung may not be detected with these tech-
niques. Conversely, the measurement of respiratory
system resistance (Rrs) and reactance (Xrs) with the forced
oscillation technique (FOT), the assessment of gas trans-
fer with the diffusing capacity of carbon monoxide (DLCO)
and inhaled histamine challenges to document airway
reactivity will provide a comprehensive assessment of
both central and peripheral lung function. To date there
have not been any published studies of comprehensive
lung function assessments of musicians and this approach
may provide a broader picture of pulmonary physiology in
W/B musicians. This study aimed to compare W/B musi-
cians’ respiratory function to a non-wind/brass (NW/B)
comparison group using measures of flows and volumes,
gas transfer, respiratory mechanics and airway respon-
siveness (AR).Methods
Subjects
Subjects, musicians and non-musicians, were recruited
through universities, professional music ensembles and
community ensembles. All participants were non-smokers,
aged between 18 and 60 years and had no current asthma ordefined as a person who had self-reported current asthma
and/or had experienced asthma symptoms and/or had used
asthma medications in the 12 months prior to the test.
People who had smoked for a significant proportion of their
lives (5 or more years with 10 or more cigarettes per day),
or who had smoked at all within 12 months of the test, were
considered to be smokers for the purpose of the study. At
the time of testing all participants were healthy, being at
least three weeks clear of any respiratory infection. Human
Research Ethics Committees at both The University of
Western Australia and Princess Margaret Hospital approved
the testing protocol. All subjects gave written consent prior
to commencing the study.
Participant categorisation
Participants were classified as W/B musicians if they played
W/B instruments (including voice) for >5 h per week and
for > 2 years. Musicians who played only non-wind/brass
instruments (e.g. string instruments and/or percussion) and
subjects who did not play any musical instruments were
classified as NW/B participants. The primary aim of the study
was to investigate lung function in W/B musicians. However,
this is, to some degree, a heterogeneous group and, there-
fore, a secondary aim was to determine lung function within
the W/B players depending on the instrument. Sub-groups
were formed based on the maximum pressure (MP) required
to play each instrument using data from the research of
Bouhuys.4 The W/B musicians were divided into two sub-
groups as follows: lowMP (MP< 100mmHg, including singers)
and highMP (MP > 100 mmHg).
Protocol
The participants made one visit to the respiratory medicine
laboratory at Princess Margaret Hospital for testing. The visit
involved an administered respiratory questionnaire,17 height
and weight measurement and lung function testing per-
formed in the following order: FOT, static lung volumes using
multiple breath nitrogen washout, gas transfer by DLCO,
spirometry and histamine challenge testing. All static lung
volumes, DLCO, histamine challenge and spirometry
measurements were performed on a SensorMedics Encore
lung function system (VMax software version 20.5; Sensor-
Medics, Viasys, Yorba Linda, USA). Atopic status was deter-
mined using a skin prick test (SPT). All lung function tests
were done according to standard protocols (see below). All
testing was conducted by the same investigator (AF) and the
same instructions were provided to each of the participants.
Techniques
Forced oscillation test
Forced oscillation tests were performed on a commercially
available system (I2M Chess Medical, Belgium) that used
a pseudo-random forcing signal (4e48 Hz) and according to
international guidelines.18 The machine was fitted with
a mouthpiece incorporating a bacterial filter (Suregard,
Bird Healthcare, Melbourne, Australia) and measurements
were adjusted for the impedance properties of this
mouthpiece/filter set-up.
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in a seated position and with a nose-clip applied. Subjects
supporting their cheeks with their hands to minimise
shunting of the forcing signal. The outcome variables of
interest were resistance and reactance at the frequency of
6 Hz (Rrs6 and Xrs6, respectively). Measurements were
considered acceptable if they met the following criteria: no
noted swallowing, jaw or mouth movement, talking or
other noises; no leak around mouthpiece due to poor seal;
and similar respiratory rates. The mean of at least three
acceptable measures are reported.
Static lung volumes
Lung volumes were obtained in two stages: Measurements
of FRC were obtained by multiple breath nitrogen washout
(MBNW) according to international guidelines.19 Briefly,
participants inhaled 100% oxygen until the exhaled nitrogen
concentration decreased to <1.5% for a minimum of three
breaths. Measurements of FRC were followed by repeated
slow VC manoeuvres. The mean of a minimum of two
acceptable FRC measurements within 150 mL of each other
was recorded. Total lung capacity was calculated as
FRC þ inspiratory capacity. The best of at least two VC
trials were recorded where the VC measurements were
within 200 mL. Measurements of VC were only used where
the corresponding MBW produced acceptable results.
Gas transfer
Measurements of gas transfer were assessed using the
single-breath diffusing capacity for carbon monoxide
(DLCO) technique according to international guidelines.
20
Participants began the test with tidal breathing before
exhaling completely, and then rapidly inhaling a mixture of
gasses containing a small concentration of CO (0.3%). The
requirement was inhalation of the gas mixture to greater
than 85% of VC in a 2.5 s time period. Subjects then held
their breath for 10 s before steadily exhaling to complete
the test. The mean of two acceptable measures was
recorded, where DLCO was within 3 units (mL/mmHg/min)
and alveolar volume (VA) was within 150 mL.
Spirometry
Spirometry was measured according to ATS/ERS guide-
lines21 using a SensorMedics Encore lung function system
(SensorMedics, Viasys, Yorba Linda, USA) and VMax soft-
ware (Version 20-5). For each spirometry measurement, the
participant was seated with a nose-clip fitted and lips
sealed around a mouthpiece incorporating a bacterial filter
as they established a pattern of tidal breathing. Next, the
subject performed the three phases of the test: (a)
maximal inspiration; (b) a blast of exhalation; and (c)
continued exhalation to the end of the test. For the exha-
lation phase, each subject was instructed to blow out as
hard and fast as possible and to continue to exhale until
their lungs were empty. The subjects were encouraged to
continue to exhale for as long as possible.
A minimum of three acceptable tests were obtained and
a testing session was considered repeatable if the highest
and second highest FVC and FEV1 measurements were
within 150 mL of each other. The largest FEV1 and FVC were
recorded. Other measures of spirometry were derived from
the trial with the largest sum of FEV1 and FVC. To ensurereproducibility each subject was strongly encouraged to
give their best effort for each manouevre and ATS/ERS
quality control measures were used to evaluate the
acceptability of each measurement.
Histamine challenge
A histamine challenge was conducted using doubling dose
solutions of saline (0.9%) diluted histamine from 0.1 mg/mL
to 32 mg/mL, according to guidelines by Crapo et al.22
Dilutions were delivered to the participants via nebulizers
(DeVilbiss 646) fitted with a mouthpiece and exhalation
filter. A flow of 6 L/min was applied to the filled nebulizer,
using a calibrated pressure-compensated flow meter
according to the following time schedule: 2 min tidal
breathing on nebulizer; spirometry manoeuvre A (30 s post-
nebulizer); spirometry manoeuvre B (90 s post-nebulizer)
and 90 s change-over time to next concentration.
Spirometry was the endpoint measure and two accept-
able measures were required after the saline inhalation.
The highest FEV1 was used as the baseline measurement for
the remainder of the test. Following each increasing dose
of histamine, the participants completed two abbreviated
FVC manoeuvres. Since only FEV1 was being considered
(and not FVC), the effort was terminated after at least 1 s
of forced expiration. The final dose was indicated by a drop
in FEV1 of at least 20%. To complete the test, 400 mg of
salbutamol (Ventolin, GSK) was administered, followed by
a wait period (minimum 10 min), then post-test to check
that participant’s post-test FEV1 was within 10% of base-
line. A dose-response slope (DRS) calculation was used to
quantify the degree of AR. This continuous variable was
measured as the percentage decrease in FEV1 from post-
saline divided by the cumulative histamine dose.23
Skin prick test
Skin prick tests were carried out using histamine phosphate
(10 mg/mL) as a positive control and saline as a negative
control, testing for 10 common allergen solutions. Any
response with a weal size of at least 3 mm mean diameter
which was greater than the weal size of the positive control
was considered a significant response. Results were recor-
ded as a dichotomous variable (atopic or non-atopic).
Statistical analysis
The primary objective was to compare W/B musicians’
respiratory function with that of NW/B participants.
Reference equations based on previous research were
available for the majority of the lung function measures
including static lung volumes, spirometry, FOT and DLCO.
Spirometry24 and FOT results25 were converted to z-scores,
while static lung volume26 and DLCO
27 results were
assessed as percent-predicted values. All these data were
normally distributed. The DRS was transformed to its
natural log transformation to achieve a near normal
distribution. Comparisons between W/B and NW/B groups
were done using Students T-tests. Unlike other data, DRS
had not been standardised for height, weight, sex and age.
Therefore, DRS was analysed using linear regression models
to control for these factors. The model also included
baseline FEV1 and atopy as these are important factors
764 A.G. Fuhrmann et al.associated with AR Franklin et al.32 For the secondary
analysis, One Way Analysis of Variance (ANOVA) was used to
compare each outcome between the 3 groups, NW/B,
lowMP and highMP.
Sample size and power calculation
The study by Deniz et al.7 detected a decrease in FEV1 of
approximately 10% in W/B musicians compared to non-
musician controls. For this reason, FEV1 was selected to
power the current study. It was hypothesised that FEV1
among NW/B participants would be similar to the general
population. Based on the final sample size and distribution
of FEV1 in the control group the study had >80% power to
detect a 7% decrease in FEV1 among W/B musicians
compared to NW/B subjects.
Results
Initially, 125 participants were involved in the study. After
exclusions due to subject selection criteria and unaccept-
able data, 102 subjects were included in the final data
analysis (55 W/B musicians and 47 NW/B subjects). The
participant groups were similar in terms of height, weight,
atopy and sex distribution, though N/W participants were
significantly older than the W/B musicians (Table 1). The
mean number of years of W/B instrument playing for the
W/B participant group was 14.4  8.5 (2, 40) (mean  SD
(range)). Only two participants had played for less than five
years. All W/B musicians were actively playing at the time
of recruitment. The mean number of instrument playing
hours per day for the W/B group was 1.7  19.8 (0.2, 5.0).
The distribution of participants by sub-groups and instru-
ments played is shown in Table 2.
Lung function
All spirometry and static lung volume measurements were
similar between NW/B and W/B participants, with the
exception of RV/TLC which was significantly decreased
among W/B musicians (p Z 0.03) (Table 3). Respiratory
resistance (Rrs6) assessed using FOT was significantly
increased in W/B musicians (pZ 0.02) with reactance (Xrs6)
not different between the groups. The participant groups
were similar in terms of gas transfer (DLCO/VA) and AR
measured by dose-response slope. There were no differ-
ences between participant MP sub-groups in any measure of
lung function (data not shown).Table 1 Wind and Brass and non-wind/brass participant demog
NW/B, n Z 47
Age (years) 34.9  11.7 (19, 61)
Height (cm) 171.0  7.8 (154, 183)
Weight (kg) 69.1  11.4 (47.2, 93.0)
Atopy 23 (49% atopic)
Sex 20 (43% male)
Data presented as mean  SD (range) or number of cases (%). Differenc
(95% CI) difference or Chi-square p value.Discussion
In this study an extensive battery of respiratory function
tests were performed on musicians who played W/B
instruments and participants who either played NW/B
instruments or no instruments at all. The primary aim was
to compare these groups in terms of respiratory function.
The vast majority of test results did not differ between W/B
and NW/B participants, with two exceptions. Firstly, mean
RV/TLC was lower among W/B musicians. Secondly, respi-
ratory resistance (Rrs6) was higher among W/B musicians
compared to NW/B musicians.
Past research on musicians’ respiratory function has
focused on lung flows and volumes. The majority of
previous studies using spirometry have not reported
differences between W/B musicians and NW/B musicians11
nor non-musicians.9 However, one study showed dimin-
ished spirometry in W/B players compared to non-musician
controls and the authors concluded that playing W/B
instruments may have a deleterious impact on lung func-
tion.7 The current results agree with the majority of past
studies, suggesting that spirometry is similar between non-
asthmatic W/B musicians and healthy people who do not
play these instruments.
Increased respiratory flows and lung capacity (particu-
larly VC) are considered to be an asset for the playing of
W/B instruments.15,16 Having larger volumes of air at one’s
disposal gives the musician greater ‘power’ with which to
create, manipulate and sustain musical tone on an instru-
ment. Previous studies suggested that VC was increased
among W/B players, though the inclusion of smokers,4 the
lack of information about participants’ smoking status6 or
lack of significance testing5 may undermine the validity of
these findings. Other studies suggesting larger VC among
W/B players have compared measurements with pop-
ulation predicted values only.14e16 In the current study, W/
B musicians’ mean VC (104.3%) was not different to the
NW/B subjects (106.4%). The results agreed with the find-
ings of Borgia et al.,9 Navratil and Rejsek10 and Heller
et al.13 which also reported no differences in lung volumes.
Musicians’ ability to control airflow is likely to be more
closely associated with skill level than physical lung
capacity.15
There has been some speculation that W/B playing may
be linked with emphysema due to increased intrapulmonary
pressures.28,29 Emphysema is characterised by enlargement
of the airspaces distal to the terminal bronchioles30 corre-
sponding with destruction of the alveolar walls.31 Air
trapping, as happens in emphysema, results in increasedraphics.
W/B, n Z 55 T-test
28.8  11.0 (17, 60) 6.12 (1.66, 10.57)
170.5  8.3 (155, 186) 0.43 (2.76, 3.62)
71.9  17.2 (48.4, 120.2) 2.86 (8.71, 2.98)
24 (44% atopic) 0.65
23 (42% male) 0.94
es between wind/brass musicians and controls presented as mean
Table 2 Participant sub-groups and inclusive instruments.
Participant groups NW/B (n Z 47) W/B sub-groups
lowMP
(n Z 38)
highMP
(n Z 17)
Instruments NW/B musicians (18)
Non-musicians (29)
Baritone horn (3)
Bassoon (1)
Clarinet (5)
Flute (10)
Saxophone (5)
Tuba (3)
Voice (11)
French horn (4)
Trombone (6)
Trumpet (6)
Bagpipes (1)
Data presented as number of participants (n) in each sub-group and specific musical instrument played.
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playing being associated with air trapping, since W/B
players had lower mean RV/TLC than NW/B participants
although the difference (mean difference 2.70%) is unlikely
to be physiologically relevant.
Impaired gas transfer, as evidenced by reduced DLCO, is
another characteristic of emphysema. Therefore, if the
speculation on W/B players developing emphysema was
plausible, it would be reasonable to expect decreased DLCO
and/or DLCO/VA among W/B musicians. On the contrary,
DLCO/VA mean values for W/B and NW/B participants in the
current study were statistically similar, further suggesting
that W/B playing is not linked to the functional abnormal-
ities of the lung parenchyma. However, the majority of
participants in the current study were relatively young with
varying degrees of playing experience (the median length
of time of playing was 12 years, with a median daily playing
time of 1 h and 10 min). Potential beneficial or detrimental
effects of W/B playing on gas transfer may be more likely to
appear in an older age group with a longer history of playing
these instruments. Therefore research in an older group ofTable 3 Comparison of respiratory function means between NW
Test Variable NW/B (n Z 47) W
Spirometrya FEV1 0.07  1.1 (2.1, 2.3)
FVC 0.06  1.2 (2.6, 2.1) 
FEV1/FVC 0.00  0.8 (1.8, 1.5)
Lung volumesb TLC 99.7  11.9 (82, 128)
RV 84.6  22.1 (37, 144)
FRC 100.2  21.6 (63, 149)
RV/TLCc 24.3  6.2 (9, 34)
FOTa Rrs6 0.41  1.01 (2.3, 2.9)
Xrs6 0.15  1.05 (2.0, 2.0) 
Gas transferb DLCO 88.14  12.6 (63, 112) 8
VA 98.30  13.1 (74, 123)
DLCO/VA 90.49  11.8 (73, 127)
AR DRS 2.57  3.6 (0.1, 14.0)
Data presented as mean  SD (range) or number of cases (%). Differenc
(95% CI) difference or Chi-square p value. AR: airway responsiveness;
Significant differences (p < 0.05) noted in bold.
Data expressed as:
a z-scores.
b Percent-predicted values.
c Ratio of geometric values (not percent-predicted).W/B musicians is necessary to fully determine the impact,
if any, of W/B on the development of emphysema.
Forced oscillation tests can provide information on airway
calibre (Rrs) and lung stiffness (Xrs). Measurements of airway
calibre have not previously been used in the context of
research on musicians’ lung function. It is possible that
changes in the peripheral airways may be observed using
FOT, while more central airway changes may not yet be
measurable. In the current study Rrs6 z-scores were signifi-
cantly increased in theW/B groupwhen compared to the non
W/B control group. The observed increase in Rrs6 amongW/B
musicians may indicate subtle changes in airway inflamma-
tion, remodelling or other pathophysiological processes
occurring in W/B musicians. Plamenac and Niculin’s8 obser-
vation of “marked eosinophilia” in sputum samples of W/B
musicians, suggests that such changes are plausible. In
a study of fractional exhaled nitric oxide measurements on
the same cohort of participants as the current study, theW/B
musicians exhibited higher concentrations, which could be
indicative a higher degree of eosinophilic airway inflamma-
tion, though the differences were small and not clinically or/B and W/B participants.
/B (n Z 55) Group differences
0.01  1.0 (1.8, 2.2) 0.07 (0.48, 0.33) p Z 0.73
0.06  0.9 (2.1, 2.1) 0.00 (0.42, 0.42) p Z 1.00
0.08  0.9 (1.5, 1.8) 0.08 (0.42, 0.25) p Z 0.62
97.4  11.6 (79, 120) 2.34 (2.47, 7.14) p Z 0.33
80.0  26.4 (14, 144) 4.63 (5.38, 4.64) p Z 0.36
93.1  19.0 (54, 145) 7.11 (1.02, 15.23) p Z 0.09
21.6  5.8 (4, 34) 2.70 (0.27, 5.14) p Z 0.03
0.09  1.07 (2.3, 3.0) L0.50 (L0.9, L0.1) p Z 0.02
0.23  1.28 (3.1, 2.3) 0.38 (0.1, 0.9) p Z 0.10
6.26  14.0 (65e127) 1.88 (4.1, 7.9) p Z 0.53
97.9  10.6 (77, 120) 0.44 (4.8, 5.7) p Z 0.87
90.0  16.1 (65, 137) 0.53 (5.8, 6.9) p Z 0.87
3.06  4.0 (0.1, 18) 0.05, p Z 0.67
es between wind/brass musicians and controls presented as mean
DRS: dose response slope.
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influence exhaled nitric oxide Fuhrmann et al.33 However,
the current data did not reveal a clear pattern of altered
airway calibre among W/B players. Further investigation of
respiratory mechanics using a larger sample of musicians
with a broader range of experience would be necessary to
give a clearer picture of possible altered airway calibre
among this occupational group.
In contrast to Rrs6 the predicted Xrs6 was not different
between the two groups. This result when combined with
the normal DLCO further strengthens the conclusion that
the use of wind or brass instruments does not alter the
physiological function of the lung parenchyma.
It is important to consider differences between the
instruments, since it is plausible that instruments that
require higher pressures place greater demands on the
respiratory system, and are more likely to be associated
with changes in respiratory function. There was no
evidence in this study that maximum pressure ‘profiles’ of
W/B instruments are associated with differences in lung
function. However, the sub-groups, particularly the highMP
group, were small and the study was not sufficiently pow-
ered to determine if there was a difference based on
pressure profiles. A larger study would be needed to
investigate this further.
Results from this study suggest that the vast majority of
respiratory function measures are similar between W/B
musicians and people who do not play these instruments.
The observed decrease in RV/TLC among W/B musicians
and the similar DLCO between participant groups provide
evidence against W/B playing being associated with air
trapping as in emphysema. Increased Rrs6 may indicate
some pathophysiological difference in W/B musicians’
airways, though the data did not reveal a consistent pattern
of altered airway calibre. Although the observed differ-
ences were significant, they were small in magnitude and
need to be confirmed through further research. With the
exception of RV/TLC, musicians’ respiratory flows and/or
volumes appear to have no association with type of
instrument played. This could be interpreted in two ways.
The choice to play a W/B instrument is not likely to be
impacted by one’s lung flows or volumes. Neither is there
any consistent evidence that the physical practice of
playing a W/B instrument alters flows or volumes. It seems
reasonable to surmise that W/B musicians’ ability to sustain
long musical phrases with expression is a result of having
learned to control airflow, not necessarily due to having
naturally better lung function.Acknowledgements
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